AstraZeneca’s Oral GLP-1 Elecoglipron Shows Weight and Glucose Benefits
Share on Pinterest AstraZeneca’s new oral GLP-1 pill showed promising results for weight loss and blood sugar in a phase 2 trial. Guido Mieth/Getty Images A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial. Experts say GLP-1 drugs